Stay updated with breaking news from Carrie Bourdow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important...
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies...
Operator: Greetings and welcome to Trevena, Inc. Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
26.06.2023 - OLINVYK-treated patients (n=201) had a statistically significant ~$8,750 (19%) lower cost per admission and ~1.4 day (20%) reduced average length of hospital stay, compared to matched patients treated with other IV opioids (n=982) New respiratory ... Seite 1
Detailed price information for Trevena Inc (TRVN-Q) from The Globe and Mail including charting and trades.